Saturday, May 17, 2008

FDA Approves Risperdal in Children

The FDA recently approved the use of the antipsychotic Risperdal in children and adolescents with bipolar disorder and schizophrenia. Our Mental Health Experts weigh in on the implications of this decision.

Featured

More

  • Font size font size A A A
  • |Email this page Email this page
  • |AddThis Social Bookmark Button